These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 2108315)

  • 1. Site-directed mutagenesis of the SH2- and SH3-coding domains of c-src produces varied phenotypes, including oncogenic activation of p60c-src.
    Hirai H; Varmus HE
    Mol Cell Biol; 1990 Apr; 10(4):1307-18. PubMed ID: 2108315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of the SH3 domain of Src interferes with regulation by the phosphorylated carboxyl-terminal tyrosine.
    Okada M; Howell BW; Broome MA; Cooper JA
    J Biol Chem; 1993 Aug; 268(24):18070-5. PubMed ID: 7688738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the proto-oncogene p60c-src by point mutations in the SH2 domain.
    O'Brien MC; Fukui Y; Hanafusa H
    Mol Cell Biol; 1990 Jun; 10(6):2855-62. PubMed ID: 2111444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of SH2 and SH3 deletions on the functional activities of wild-type and transforming variants of c-Src.
    Seidel-Dugan C; Meyer BE; Thomas SM; Brugge JS
    Mol Cell Biol; 1992 Apr; 12(4):1835-45. PubMed ID: 1549129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.
    Matsuda M; Reichman CT; Hanafusa H
    J Virol; 1992 Jan; 66(1):115-21. PubMed ID: 1370084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
    Jong SM; Zong CS; Dorai T; Wang LH
    J Virol; 1992 Aug; 66(8):4909-18. PubMed ID: 1321277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.
    Mayer BJ; Hanafusa H
    J Virol; 1990 Aug; 64(8):3581-9. PubMed ID: 1695251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions in the SH2 domain of p60v-src prevent association with the detergent-insoluble cellular matrix.
    Fukui Y; O'Brien MC; Hanafusa H
    Mol Cell Biol; 1991 Mar; 11(3):1207-13. PubMed ID: 1705002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletional analysis of the N-terminal half of the lyn gene.
    Sasaki M
    Kobe J Med Sci; 1990 Dec; 36(5-6):137-51. PubMed ID: 2087092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host range mutants of v-src: alterations in kinase activity and substrate interactions.
    Liebl EC; England LJ; DeClue JE; Martin GS
    J Virol; 1992 Jul; 66(7):4315-24. PubMed ID: 1534851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in the SH3 domain of the src oncogene which decrease association of phosphatidylinositol 3'-kinase activity with pp60v-src and alter cellular morphology.
    Wages DS; Keefer J; Rall TB; Weber MJ
    J Virol; 1992 Apr; 66(4):1866-74. PubMed ID: 1312609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophosphorylation is required for high kinase activity and efficient transformation ability of proteins encoded by host range alleles of v-src.
    Woods KM; Verderame MF
    J Virol; 1994 Nov; 68(11):7267-74. PubMed ID: 7933110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transformation-defective mutants with 5' deletions of the src gene are frequently generated during replication of Rous sarcoma virus in established quail fibroblasts.
    Barnier JV; Marx M; Dezelee P; Laugier D; Poirier F; Calothy G; Hillova J; Hill M
    Virology; 1990 Aug; 177(2):505-14. PubMed ID: 2164723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in src homology regions 2 and 3 of activated chicken c-src that result in preferential transformation of mouse or chicken cells.
    Hirai H; Varmus HE
    Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8592-6. PubMed ID: 1700434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the Src homology domains in morphological transformation by v-src.
    Tian M; Martin GS
    Mol Biol Cell; 1997 Jul; 8(7):1183-93. PubMed ID: 9243500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and sequence analysis of cDNAs encoding a 110-kilodalton actin filament-associated pp60src substrate.
    Flynn DC; Leu TH; Reynolds AB; Parsons JT
    Mol Cell Biol; 1993 Dec; 13(12):7892-900. PubMed ID: 8247004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of the carboxy terminus of p60c-src that are required for the regulation of its intrinsic kinase activity.
    Kato J; Hirota Y; Nakamura N; Nakamura N; Takeya T
    Jpn J Cancer Res; 1987 Dec; 78(12):1354-62. PubMed ID: 3123438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.
    Liu X; Marengere LE; Koch CA; Pawson T
    Mol Cell Biol; 1993 Sep; 13(9):5225-32. PubMed ID: 7689147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
    Kamps MP; Sefton BM
    Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.